Weight-loss drugs are reshaping Whole Foods, one aisle at a time

As customers trade junk food for wellness, Whole Foods is expanding its supplements aisle with tinctures inspired by Japanese herbal medicine.

Some seven million Americans are now on GLP-1 weight loss drugs, a figure expected to rise to 24 million by 2035. These medications curb users’ appetites for fatty, ultra-processed foods, and grocery stores are noticing: total sold units of doughnuts, cakes, and cookies are down by 10%, 19%, and 13%, respectively, compared to five years ago. With this drop in revenue from junk food, grocery stores need to think about how to make more money from other categories. For Whole Foods, there’s one aisle that brims with potential: supplements.